By Wyeth Ruthven, Director of Congressional and Public Relations, Health Industry Distributors Association
Across the continuum of care, tariffs remain a concern. From the factory floor to the hospital bedside, every link in the medical supply chain is impacted when tariffs are imposed on healthcare products. Each segment of the chain faces unique challenges, and we all face constraints on resources.
Manufacturers
The impact of tariffs on overseas manufacturing is readily apparent. But even domestic manufacturers will be impacted by increased tariffs, because they rely on globally sourced inputs such as resins for syringes or metals for surgical tools. Tariffs increase the cost of these materials, squeezing margins and limiting capital available for innovation and quality improvement. A recent survey of medical equipment manufacturers found that 81% predict longer lead times and supply shortages as the result of tariffs.
Distributors
Distributors have scant margin to absorb the cost of tariffs on behalf of the entire medical supply chain. Most contracts for medical products are locked in years in advance with group purchasing organizations on behalf of providers. When tariffs unexpectedly alter cost calculation of medical products, there is little leeway to revise an existing agreement.
Providers
Hospitals, nursing homes and other healthcare providers operate within tightly managed budgets, many of them tied to government reimbursement rates that do not adjust for rising input costs. When tariffs drive up prices for basic medical products, providers have little recourse. Some may cut back on stockpiling safety reserves, limit investments in advanced care tools, or shift purchasing toward lower-cost alternatives. When surveyed about the impact of tariffs on their health systems, 94% of healthcare administrators said they foresee buying less equipment or delaying upgrades to mitigate financial strain.
Patients
Ultimately, patients will feel the cumulative effects of these pressures on the medical supply chain. Tariff-inspired shortages of critical medical products can translate into delayed procedures, limited access to care, and increased out-of-pocket costs. Approximately 84% of payer executives expect to see higher claims costs due to increased pricing on medical treatments and drugs, and 48% of payer executives believe that insurance premiums will rise within the next 12 months as a direct consequence of increased supply chain expenses.
The challenge
Our healthcare system depends on a reliable, affordable, and diverse flow of medical goods. Tariffs threaten to disrupt that flow at every point along the continuum of care. No single segment of the medical supply chain can carry the weight of tariffs on its own. Because we are navigating this together, we all have a role to play: to ensure that tariffs do not compromise the resilience, efficiency, or equity of our healthcare system.
